AJMC December 4, 2025
Brooke McCormick, Jennifer Graff, PharmD, Brian Reid, MS Fact checked by: Christina Mattina

Jennifer Graff, PharmD, and Brian Reid, MS, emphasize that DTC pharmacy models can give patients more convenient access to medications but may increase out-of-pocket costs.

Jennifer Graff, PharmD, of Innov8 Health Policy, and Brian Reid, MS, of Reid Strategic, discuss the advantages and drawbacks of direct-to-consumer (DTC) pharmacy models for patients and manufacturers.

They note that DTC models can offer patients faster, more convenient access to medications while allowing manufacturers to engage more directly with consumers. However, these models may raise out-of-pocket costs for patients, the experts warn.

Learn more about the impact of DTC models here.

This transcript has been lightly edited for clarity; captions were auto-generated.

Transcript

What key advantages do DTC models offer to consumers and manufacturers,...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech
What’s new with GLP-1s
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model

Share Article